Join Hastings Center for Bioethics’ President and CEO Vardit Ravitsky at the Endpoints AI day, AI in Biopharma: Where Promise Meets Pressure.

Panel discussion: The Ethics of AI in Science and Healthcare

Silicon Valley is about moving fast, while the world of medicine starts with first, doing no harm. How does that tension play out with AI’s growing role in everything from lab research to clinical trials to medical care? We’ll talk through the biggest ethical questions for the field, strategies to build responsible AI, and whether the societal challenges will ultimately be bigger than the technological.  

Panelists:

Inmaculada de Melo-Martín
Professor of Medical Ethics
Weill Cornell Medicine

Elliott Green
CEO
Dandelion Health

Chris Fussell
Co-founder & President, Operations
Lila Sciences

Vardit Ravitsky
President & CEO
The Hastings Center for Bioethics

Andrew Dunn, Moderator
Senior Biopharma Correspondent
Endpoints News